The factor V Leiden gene mutation and prothrombin gene mutation are associated with a 3–5-fold increase in the risk of a first episode of VTE, in contrast to antithrombin deficiency, which may increase the risk by 14-fold (see Table 1) [58,59,60]. This evidence concerns the gene F5 and hereditary antithrombin deficiency.